Literature DB >> 29784935

A causal mechanism for childhood acute lymphoblastic leukaemia.

Mel Greaves1.   

Abstract

In this Review, I present evidence supporting a multifactorial causation of childhood acute lymphoblastic leukaemia (ALL), a major subtype of paediatric cancer. ALL evolves in two discrete steps. First, in utero initiation by fusion gene formation or hyperdiploidy generates a covert, pre-leukaemic clone. Second, in a small fraction of these cases, the postnatal acquisition of secondary genetic changes (primarily V(D)J recombination-activating protein (RAG) and activation-induced cytidine deaminase (AID)-driven copy number alterations in the case of ETS translocation variant 6 (ETV6)-runt-related transcription factor 1 (RUNX1)+ ALL) drives conversion to overt leukaemia. Epidemiological and modelling studies endorse a dual role for common infections. Microbial exposures earlier in life are protective but, in their absence, later infections trigger the critical secondary mutations. Risk is further modified by inherited genetics, chance and, probably, diet. Childhood ALL can be viewed as a paradoxical consequence of progress in modern societies, where behavioural changes have restrained early microbial exposure. This engenders an evolutionary mismatch between historical adaptations of the immune system and contemporary lifestyles. Childhood ALL may be a preventable cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29784935      PMCID: PMC6986894          DOI: 10.1038/s41568-018-0015-6

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  187 in total

1.  A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.

Authors:  Sohela Shah; Kasmintan A Schrader; Esmé Waanders; Andrew E Timms; Joseph Vijai; Cornelius Miething; John T Sandlund; Marshall S Horwitz; Charles G Mullighan; Kenneth Offit; Jeremy Wechsler; Jun Yang; James Hayes; Robert J Klein; Jinghui Zhang; Lei Wei; Gang Wu; Michael Rusch; Panduka Nagahawatte; Jing Ma; Shann-Ching Chen; Guangchun Song; Jinjun Cheng; Paul Meyers; Deepa Bhojwani; Suresh Jhanwar; Peter Maslak; Martin Fleisher; Jason Littman; Lily Offit; Rohini Rau-Murthy; Megan Harlan Fleischut; Marina Corines; Rajmohan Murali; Xiaoni Gao; Christopher Manschreck; Thomas Kitzing; Vundavalli V Murty; Susana Raimondi; Roland P Kuiper; Annet Simons; Joshua D Schiffman; Kenan Onel; Sharon E Plon; David Wheeler; Deborah Ritter; David S Ziegler; Kathy Tucker; Rosemary Sutton; Georgia Chenevix-Trench; Jun Li; David G Huntsman; Samantha Hansford; Janine Senz; Thomas Walsh; Ming Lee; Christopher N Hahn; Kathryn Roberts; Mary-Claire King; Sarah M Lo; Ross L Levine; Agnes Viale; Nicholas D Socci; Katherine L Nathanson; Hamish S Scott; Mark Daly; Steven M Lipkin; Scott W Lowe; James R Downing; David Altshuler
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

2.  Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.

Authors:  Meike Fischer; Maike Schwieger; Stefan Horn; Birte Niebuhr; Anthony Ford; Susanne Roscher; Ulla Bergholz; Mel Greaves; Jürgen Löhler; Carol Stocking
Journal:  Oncogene       Date:  2005-11-17       Impact factor: 9.867

3.  RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.

Authors:  Elli Papaemmanuil; Inmaculada Rapado; Yilong Li; Nicola E Potter; David C Wedge; Jose Tubio; Ludmil B Alexandrov; Peter Van Loo; Susanna L Cooke; John Marshall; Inigo Martincorena; Jonathan Hinton; Gunes Gundem; Frederik W van Delft; Serena Nik-Zainal; David R Jones; Manasa Ramakrishna; Ian Titley; Lucy Stebbings; Catherine Leroy; Andrew Menzies; John Gamble; Ben Robinson; Laura Mudie; Keiran Raine; Sarah O'Meara; Jon W Teague; Adam P Butler; Giovanni Cazzaniga; Andrea Biondi; Jan Zuna; Helena Kempski; Markus Muschen; Anthony M Ford; Michael R Stratton; Mel Greaves; Peter J Campbell
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

4.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-01-02       Impact factor: 47.728

5.  Childhood acute leukemia, early common infections, and allergy: The ESCALE Study.

Authors:  Jérémie Rudant; Laurent Orsi; Florence Menegaux; Arnaud Petit; André Baruchel; Yves Bertrand; Anne Lambilliotte; Alain Robert; Gérard Michel; Geneviève Margueritte; Julie Tandonnet; Françoise Mechinaud; Pierre Bordigoni; Denis Hémon; Jacqueline Clavel
Journal:  Am J Epidemiol       Date:  2010-08-31       Impact factor: 4.897

6.  Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.

Authors:  Andrea Inthal; Gerd Krapf; Dominik Beck; Ruth Joas; Max O Kauer; Lukas Orel; Gerhard Fuka; Georg Mann; E Renate Panzer-Grümayer
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

7.  Germline genomic variants associated with childhood acute lymphoblastic leukemia.

Authors:  Lisa R Treviño; Wenjian Yang; Deborah French; Stephen P Hunger; William L Carroll; Meenakshi Devidas; Cheryl Willman; Geoffrey Neale; James Downing; Susana C Raimondi; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Nat Genet       Date:  2009-08-16       Impact factor: 38.330

8.  Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Authors:  Stefan Essig; Qiaozhi Li; Yan Chen; Johann Hitzler; Wendy Leisenring; Mark Greenberg; Charles Sklar; Melissa M Hudson; Gregory T Armstrong; Kevin R Krull; Joseph P Neglia; Kevin C Oeffinger; Leslie L Robison; Claudia E Kuehni; Yutaka Yasui; Paul C Nathan
Journal:  Lancet Oncol       Date:  2014-06-19       Impact factor: 41.316

9.  Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation.

Authors:  Zhigang Lu; Jingjing Xie; Guojin Wu; Jinhui Shen; Robert Collins; Weina Chen; Xunlei Kang; Min Luo; Yizhou Zou; Lily Jun-Shen Huang; James F Amatruda; Tamra Slone; Naomi Winick; Philipp E Scherer; Cheng Cheng Zhang
Journal:  Nat Med       Date:  2016-12-12       Impact factor: 53.440

10.  A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.

Authors:  J Vijayakrishnan; R Kumar; M Y R Henrion; A V Moorman; P S Rachakonda; I Hosen; M I da Silva Filho; A Holroyd; S E Dobbins; R Koehler; H Thomsen; J A Irving; J M Allan; T Lightfoot; E Roman; S E Kinsey; E Sheridan; P D Thompson; P Hoffmann; M M Nöthen; S Heilmann-Heimbach; K H Jöckel; M Greaves; C J Harrison; C R Bartram; M Schrappe; M Stanulla; K Hemminki; R S Houlston
Journal:  Leukemia       Date:  2016-10-03       Impact factor: 11.528

View more
  116 in total

1.  Untargeted adductomics of newborn dried blood spots identifies modifications to human serum albumin associated with childhood leukemia.

Authors:  Yukiko Yano; Courtney Schiffman; Hasmik Grigoryan; Josie Hayes; William Edmands; Lauren Petrick; Todd Whitehead; Catherine Metayer; Sandrine Dudoit; Stephen Rappaport
Journal:  Leuk Res       Date:  2019-11-06       Impact factor: 3.156

2.  The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns.

Authors:  Daniel Hein; Karin Dreisig; Markus Metzler; Shai Izraeli; Kjeld Schmiegelow; Arndt Borkhardt; Ute Fischer
Journal:  Blood       Date:  2019-10-17       Impact factor: 22.113

Review 3.  Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.

Authors:  Jianfeng Li; Yuting Dai; Liang Wu; Ming Zhang; Wen Ouyang; Jinyan Huang; Saijuan Chen
Journal:  Front Med       Date:  2021-01-05       Impact factor: 4.592

4.  Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia.

Authors:  Manuel Abecasis; Nicholas C P Cross; Manuel Brito; Isabelina Ferreira; Kathleen M Sakamoto; Nobuko Hijiya; Joannah Score; Robert Peter Gale
Journal:  Leukemia       Date:  2020-07-06       Impact factor: 11.528

5.  Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model.

Authors:  Nina Richartz; Eva Duthil; Anthony Ford; Elin Hallan Naderi; Sampada Bhagwat; Karin M Gilljam; Marta Maria Burman; Ellen Ruud; Heidi Kiil Blomhoff; Seham Skah
Journal:  Blood Adv       Date:  2019-11-12

Review 6.  Prognostic Impact of Somatic Copy Number Alterations in Childhood B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Beatriz Rosales-Rodríguez; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré; Haydeé Rosas-Vargas
Journal:  Curr Oncol Rep       Date:  2020-11-14       Impact factor: 5.075

7.  Untargeted metabolomics profiling and hemoglobin normalization for archived newborn dried blood spots from a refrigerated biorepository.

Authors:  Miao Yu; Georgia Dolios; Vladimir Yong-Gonzalez; Olle Björkqvist; Elena Colicino; Jonas Halfvarson; Lauren Petrick
Journal:  J Pharm Biomed Anal       Date:  2020-08-23       Impact factor: 3.935

8.  Maternal Infection in Pregnancy and Childhood Leukemia: A Systematic Review and Meta-analysis.

Authors:  Jian-Rong He; Rema Ramakrishnan; Jane E Hirst; Audrey Bonaventure; Stephen S Francis; Ora Paltiel; Siri E Håberg; Stanley Lemeshow; Sjurdur Olsen; Gabriella Tikellis; Per Magnus; Michael F G Murphy; Joseph L Wiemels; Martha S Linet; Terence Dwyer
Journal:  J Pediatr       Date:  2019-12-04       Impact factor: 4.406

9.  Leveraging Genome and Phenome-Wide Association Studies to Investigate Genetic Risk of Acute Lymphoblastic Leukemia.

Authors:  Eleanor C Semmes; Jayaram Vijayakrishnan; Chenan Zhang; Jillian H Hurst; Richard S Houlston; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

10.  An intact gut microbiome protects genetically predisposed mice against leukemia.

Authors:  Carolina Vicente-Dueñas; Stefan Janssen; Marina Oldenburg; Franziska Auer; Inés González-Herrero; Ana Casado-García; Marta Isidro-Hernández; Javier Raboso-Gallego; Philipp Westhoff; Aleksandra A Pandyra; Daniel Hein; Katharina L Gössling; Diego Alonso-López; Javier De Las Rivas; Sanil Bhatia; Francisco Javier García-Criado; María Begoña García-Cenador; Andreas P M Weber; Karl Köhrer; Julia Hauer; Ute Fischer; Isidro Sánchez-García; Arndt Borkhardt
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.